Executive Summary
1 Market Overview
1.1 Advent and Evolution of Molecular Imaging
1.1.1 Advantages of Molecular Imaging
1.2 Emerging Trends in Medical Imaging and Impact on Molecular Imaging Market
1.3 Awaited Technological Advancements
1.4 Global Molecular Imaging Market Scenario
1.4.1 Global Molecular Imaging Addressable Market and Future Potential (2018-2029)
1.4.2 Assumptions and Limitations

2 Market Dynamics
2.1 Overview
2.2 Impact Analysis
2.3 Market Drivers
2.3.1 Rising Incidence of Disorders Inciting the use of Molecular Imaging
2.3.2 Utilization of Molecular Imaging to Inform Advances in Precision Medicine
2.3.3 Increased Penetration of Digital Platforms
2.4 Market Restraints
2.4.1 Lack of Specificity for the Diagnosis of Infectious Diseases
2.4.2 Stringent Regulatory Requirements
2.4.3 Poor Reimbursement Scenario
2.5 Market Opportunities
2.5.1 Advent of Multimodality Reporter Genes
2.5.2 Rise in Strategic Collaborations
2.5.3 Significant Technological Advancements in Cardiac Imaging and Oncology

3 Competitive Landscape
3.1 Key Strategies and Developments (2016-2019)
3.1.1 Joint Ventures, Collaborations, and Partnerships
3.1.2 Mergers and Acquisitions
3.1.3 Product Launches and Enhancements
3.1.4 Awards, Recognitions, and Others
3.1.5 Product Approvals
3.1.6 Business Expansion Activities
3.2 Market Share Analysis
3.2.1 Global Molecular Imaging Systems Market Share Analysis
3.2.2 Global Molecular Imaging Agents Market Share Analysis
3.2.3 Global Molecular Imaging Software Market Share Analysis

4 Industry Insights
4.1 Legal Requirements and Regulations
4.1.1 Regulations in the U.S.
4.1.2 Regulations in Europe
4.1.3 Regulations in Other Countries
4.1.4 Consortiums, Associations, and Regulatory Bodies
4.2 Physicians’ Perception

5 Global Molecular Imaging Market (by Product)
5.1 Overview
5.2 Imaging Systems
5.2.1 Multimodality Imaging
5.2.2 Radionuclide Imaging
5.2.2.1 Positron Emission Tomography (PET)
5.2.2.2 Single Photon Emission Computed Tomography (SPECT)
5.2.3 Magnetic Resonance Spectroscopy (MRS)
5.2.4 Ultrasound Molecular Imaging
5.2.5 Optical Imaging
5.2.5.1 Fluorescence Imaging
5.2.5.2 Bioluminescence Imaging (BLI)
5.3 Imaging Agents
5.3.1 Small Molecules
5.3.2 Peptides
5.3.3 Antibodies
5.3.4 Aptamers
5.4 Imaging Software

6 Global Molecular Imaging Market (by Application)
6.1 Overview
6.2 Clinical Applications
6.2.1 Oncology
6.2.2 Cardiology
6.2.3 Neurology
6.2.4 Gastroenterology
6.2.5 Other Applications
6.3 Preclinical Research

7 Global Molecular Imaging Market (by End User)
7.1 Overview
7.2 Hospitals
7.3 Specialty Clinics
7.4 Ambulatory Surgical Centers
7.5 Others

8 Global Molecular Imaging Market (by Region)
8.1 Overview
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Italy
8.3.5 Spain
8.3.6 Netherlands
8.3.7 Switzerland
8.3.8 Rest-of-Europe
8.4 Asia-Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest-of-Asia-Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Rest-of-Latin America
8.6 Middle East and Africa
8.6.1 Saudi Arabia
8.6.2 Israel
8.6.3 U.A.E
8.6.4 Rest-of-Middle East and Africa

9 Company profile
9.1 Advanced Accelerator Applications
9.1.1 Company Overview
9.1.2 Role of Advanced Accelerator Applications in the Global Molecular Imaging Market
9.1.3 SWOT Analysis: Advanced Accelerator Applications
9.2 Bruker Corporation
9.2.1 Company Overview
9.2.2 Role of Bruker Corporation in the Global Molecular Imaging Market
9.2.3 Financials
9.2.3.1 Key Insights on the Financial Health of the Company
9.2.4 SWOT Analysis: Bruker Corporation
9.3 Canon Inc.
9.3.1 Company Overview
9.3.2 Role of Canon Inc. in the Global Molecular Imaging Market
9.3.3 Financials
9.3.3.1 Key Insights on the Financial Health of the Company
9.3.4 SWOT Analysis: Canon Inc.
9.4 Cardinal Health
9.4.1 Company Overview
9.4.2 Role of Cardinal Health in the Global Molecular Imaging Market
9.4.3 Financials
9.4.4 SWOT Analysis: Cardinal Health
9.5 DDD-Diagnostic A/S
9.5.1 Company Overview
9.5.2 Role of DDD-Diagnostic A/S in the Global Molecular Imaging Market
9.5.3 SWOT Analysis: DDD-Diagnostic A/S
9.6 Digirad Corporation
9.6.1 Company Overview
9.6.2 Role of Digirad Corporation in the Global Molecular Imaging Market
9.6.3 Financials
9.6.3.1 Key Insights on the Financial Health of the Company
9.6.4 SWOT Analysis: Digirad Corporation
9.7 ESAOTE SPA
9.7.1 Company Overview
9.7.2 Role of ESAOTE SPA in the Global Molecular Imaging Market
9.7.3 SWOT Analysis: ESAOTE SPA
9.8 General Electric Company
9.8.1 Company Overview
9.8.2 Role of General Electric Company in the Global Molecular Imaging Market
9.8.3 Financials
9.8.3.1 Key Insights on the Financial Health of the Company
9.8.4 SWOT Analysis: General Electric Company
9.9 Hitachi, Ltd.
9.9.1 Company Overview
9.9.2 Role of Hitachi, Ltd. in the Global Molecular Imaging Market
9.9.3 Financials
9.9.3.1 Key Insights on the Financial Health of the Company
9.9.4 SWOT Analysis: Hitachi, Ltd.
9.10 Koninklijke Philips N.V.
9.10.1 Company Overview
9.10.2 Role of Koninklijke Philips N.V. in the Global Molecular Imaging Market
9.10.3 Financials
9.10.3.1 Key Insights on the Financial Health of the Company
9.10.4 SWOT Analysis: Koninklijke Philips N.V.
9.11 PerkinElmer Inc.
9.11.1 Company Overview
9.11.2 Role of PerkinElmer Inc. in the Global Molecular Imaging Market
9.11.3 Financials
9.11.3.1 Key Insights on the Financial Health of the Company
9.11.4 SWOT Analysis: PerkinElmer Inc.
9.12 Positron Corporation
9.12.1 Company Overview
9.12.2 Role of Positron Corporation in the Global Molecular Imaging Market
9.12.3 SWOT Analysis: Positron Corporation
9.13 Siemens Healthineers AG
9.13.1 Company Overview
9.13.2 Role of Siemens Healthineers AG in the Global Molecular Imaging Market
9.13.3 Financials
9.13.3.1 Key Insights on the Financial Health of the Company
9.13.4 SWOT Analysis: Siemens Healthineers AG
9.14 SurgicEye GmbH
9.14.1 Company Overview
9.14.2 Role of SurgicEye GmbH in the Global Molecular Imaging Market
9.14.3 SWOT Analysis: SurgicEye GmbH
9.15 Thermo Fisher Scientific
9.15.1 Company Overview
9.15.2 Role of Thermo Fisher Scientific in the Global Molecular Imaging Market
9.15.3 Financials
9.15.3.1 Key Insights on the Financial Health of the Company
9.15.4 SWOT Analysis: Thermo Fisher Scientific

10 Research Scope and Methodology
10.1 Product Definition
10.2 Scope of Research Study
10.3 Global Molecular Imaging Market: Research Methodology